Cart
sales@molnova.com
Phenylbutazone calcium
CAS No. 70145-60-7
Phenylbutazone calcium( ——— )
Catalog No. M39533 CAS No. 70145-60-7
Phenylbutazone calcium is a calcium derivative of phenylbutazone that has anti-inflammatory effects.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | In Stock |
|
| 50MG | 1873 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePhenylbutazone calcium
-
NoteResearch use only, not for human use.
-
Brief DescriptionPhenylbutazone calcium is a calcium derivative of phenylbutazone that has anti-inflammatory effects.
-
DescriptionPhenylbutazone calcium is a calcium derivative of phenylbutazone that has anti-inflammatory effects.
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number70145-60-7
-
Formula Weight347.44
-
Molecular FormulaC19H19CaN2O2
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Ginsenoside Rd
Ginsenoside Rd may have properties that inhibit or prevent the growth of tumors.
-
(D-Arg1,D-Trp7·9,Leu...
Spantide I, a substance P analog, is a selective NK1 receptor antagonist, with Ki values of 230 nM and 8150 nM for NK1 and NK2 receptor, respectively. Spantide I provides an approach to reduce type 1 and enhance the type 2 cytokine IL-10 in the infected cornea, leading to a significant reduction in corneal perforation.
-
NubO (68–75), Ndufa4...
NubO (68–75), Ndufa4 (68–75)
